Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 1Leukemia 1Hematologic Neoplasms 1Graft vs Host Disease 1Depression 1

Interventions

Cyclophosphamide 12Methotrexate 9Antilymphocyte Serum 9fludarabine phosphate 8Tacrolimus 8Cyclosporine 8Mycophenolic Acid 6Whole-Body Irradiation 5Radiotherapy 5Busulfan 5thymoglobulin 4Sirolimus 4Methylprednisolone 4Filgrastim 4Alemtuzumab 4fludarabine 3Transplantation 3Rituximab 3Peripheral Blood Stem Cell Transplantation 3Melphalan 3Cord Blood Stem Cell Transplantation 3Thiotepa 2Therapeutics 2Stem Cell Transplantation 2Muromonab-CD3 2Immunosuppression Therapy 2Calcineurin Inhibitors 2visilizumab 1milatuzumab 1itacitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Graft vs Host Disease × Health × Clear all
NCT02976558 2019-12-18

TriCAM

University of Erlangen-Nürnberg Medical School

Phase NA Terminated
104 enrolled
Other hematologic neoplasm

Depression, Graft vs Host Disease, Leukemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡